Probe ID
|
DNA methylation difference (%)
|
P value
|
Chromosome
|
Base position
|
Gene annotation
|
---|
cg10311104
|
0.80
|
9.75E−10
|
7
|
23053899
|
FAM126A
|
TSS200
|
cg08752433
|
2.78
|
1.05E−09
|
12
|
111016566
|
PPTC7
|
Body
|
cg26314722
|
1.85
|
1.73E−09
|
1
|
234867300
| | |
cg24054898
|
1.64
|
5.91E−09
|
3
|
148721868
|
GYG1
|
Body
|
cg23684410
|
2.40
|
6.13E−09
|
11
|
116897558
|
SIK3
|
Body
|
cg00945209
|
1.91
|
9.66E−09
|
17
|
76801579
|
USP36
|
Body
|
cg18518074
|
2.29
|
1.03E−08
|
11
|
64642316
|
EHD1
|
Body
|
cg09706133
|
1.23
|
1.31E−08
|
15
|
68659758
|
ITGA11
|
Body
|
cg21522988
|
2.06
|
1.80E−08
|
12
|
29376872
|
FAR2
|
5′UTR
|
cg02656560
|
1.69
|
3.14E−08
|
17
|
19967600
| | |
cg11418177
|
2.03
|
3.50E−08
|
4
|
142636072
|
IL15
|
5′UTR
|
cg06736148
|
2.14
|
3.68E−08
|
15
|
52416833
|
GNB5
|
Body
|
cg08655071
|
1.74
|
4.74E−08
|
1
|
209928895
|
TRAF3IP3
|
TSS1500
|
cg00829438
|
−1.02
|
5.26E−08
|
9
|
136213035
|
MED22
|
Body
|
cg27541604
|
1.65
|
5.57E−08
|
1
|
159046451
|
AIM2
|
5′UTR;1stExon
|
cg03149593
|
−1.24
|
5.98E−08
|
3
|
136988095
| | |
cg14178364
|
1.44
|
6.43E−08
|
9
|
37529128
|
FBXO10
|
Body
|
cg14038731
|
1.42
|
6.70E−08
|
6
|
110732536
|
DDO
|
Body
|
cg20737259
|
−3.09
|
7.79E−08
|
4
|
95038723
| | |
cg09470958
|
1.20
|
8.35E−08
|
6
|
31055471
| | |
cg13803727
|
1.43
|
8.65E−08
|
9
|
89445247
| | |
cg03402926
|
1.72
|
8.77E−08
|
11
|
27340767
| | |
cg07326387
|
−2.10
|
9.16E−08
|
4
|
44543613
| | |
cg00092992
|
1.80
|
9.69E−08
|
1
|
33596100
| | |
cg03665078
|
1.58
|
9.98E−08
|
5
|
118689961
|
TNFAIP8
|
Body
|
- Listed are all differentially methylated positions (DMPs) associated with schizophrenia (P < 1 × 10−7) with the corresponding P values and regression coefficients from the phase 1 discovery cohort. All DMPs with P < 5 × 10−5 are listed in Additional file 2: Table S3 with the corresponding P values and regression coefficients for the two independent replication cohorts